Encompass Health Corporation Common Stock (EHC) is a publicly traded Healthcare sector company. As of May 21, 2026, EHC trades at $105.99 with a market cap of $10.53B and a P/E ratio of 17.35. EHC moved +1.20% today. Year to date, EHC is -1.61%; over the trailing twelve months it is -12.93%. Its 52-week range spans $87.85 to $127.99. Analyst consensus is strong buy with an average price target of $141.25. Rallies surfaces EHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Encompass Health Prices $500M of 5.875% Senior Notes Due 2034: Encompass Health priced a private offering of $500 million of 5.875% senior notes due 2034 at par, closing expected May 29, 2026. The company will use proceeds plus available cash to redeem $400 million of 4.500% notes due 2028 and repay $100 million of revolver balances, covering related fees.
| Metric | Value |
|---|---|
| Price | $105.99 |
| Market Cap | $10.53B |
| P/E Ratio | 17.35 |
| EPS | $6.08 |
| Dividend Yield | 0.19% |
| 52-Week High | $127.99 |
| 52-Week Low | $87.85 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.07B |
| Net Income | $810.80M |
| Gross Margin | 0.00% |
6 analysts cover EHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $141.25.